CIK 0001555280
- Large accelerated filer
Zoetis Inc.
Sign in to watch- Ticker
- ZTS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 460696167
- Phone
- +1 973-822-7000
- Business address
- 10 SYLVAN WAY, PARSIPPANY, NJ, 07054
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-04 | Polzer Robert J Executive Vice President | Grant or award · Phantom Stock Unit | +582 | $49.66 | $29K | 10,624.38 |
| 2025-04-04 | Sarbaugh Keith Executive Vice President | Grant or award · Phantom Stock Unit | +130.94 | $49.66 | $7K | 814.87 |
| 2025-04-04 | FULLER JULIE Executive Vice President | Grant or award · Phantom Stock Unit | +27.11 | $49.66 | $1K | 27.11 |
| 2025-04-04 | Driscoll Rimma Executive Vice President | Grant or award · Phantom Stock Unit | +20.14 | $49.66 | $1,000 | 4,958.53 |
| 2025-04-04 | Joseph Wetteny Chief Financial Officer | Grant or award · Phantom Stock Unit | +866.47 | $49.66 | $43K | 6,173.94 |
| 2025-04-04 | PECK KRISTIN C Chief Executive Officer | Grant or award · Phantom Stock Unit | +2,759.92 | $49.66 | $137K | 57,348.23 |
| 2025-04-04 | Lagano Roxanne Executive Vice President | Grant or award · Phantom Stock Unit | +466.7 | $49.66 | $23K | 28,264.18 |
| 2025-04-01 | Hattersley Gavin Director | Option exercise | +1,451 | 2,216 | ||
| 2025-04-01 | Hattersley Gavin Director | Option exercise · Restricted Stock Unit | −1,451.51 | 0 | ||
| 2025-03-31 | Sarbaugh Keith Executive Vice President | Option exercise | +1,506 | 2,555 | ||
| 2025-03-31 | Sarbaugh Keith Executive Vice President | Shares withheld for taxes | −516 | $164.65 | $85K | 2,039 |
| 2025-03-31 | Sarbaugh Keith Executive Vice President | Option exercise · Restricted Stock Unit | −1,506.19 | 1,506 | ||
| 2025-03-28 | Sarbaugh Keith Executive Vice President | Grant or award · Phantom Stock Unit | +352.61 | $53.18 | $19K | 683.93 |
| 2025-03-28 | Ferran Astorga Jeannette Executive Vice President | Grant or award · Phantom Stock Unit | +345.28 | $53.18 | $18K | 1,652.66 |
| 2025-03-28 | Lagano Roxanne Executive Vice President | Grant or award · Phantom Stock Unit | +894.58 | $53.18 | $48K | 27,797.48 |
| 2025-03-28 | Polzer Robert J Executive Vice President | Grant or award · Phantom Stock Unit | +799.11 | $53.18 | $42K | 10,042.38 |
| 2025-03-28 | Driscoll Rimma Executive Vice President | Grant or award · Phantom Stock Unit | +381.81 | $53.18 | $20K | 4,938.39 |
| 2025-03-28 | Joseph Wetteny Chief Financial Officer | Grant or award · Phantom Stock Unit | +1,412.15 | $53.18 | $75K | 5,307.47 |
| 2025-03-28 | PECK KRISTIN C Chief Executive Officer | Grant or award · Phantom Stock Unit | +2,874.35 | $53.18 | $153K | 54,588.31 |
| 2025-03-11 | Reed Willie M Director | Sale | −1,210 | $166.14 | $201K | 11,245 |
Page 13 of 21 · 403 trades